spacer gif spacer gif spacer gif spacer gif Propose a workshop for 2011 spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online June 5, 2007
doi: 10.1242/10.1242/jcs.03460


Journal of Cell Science 120, 2053-2065 (2007)
Published by The Company of Biologists 2007
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, P.-S.
Right arrow Articles by Kuo, M.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, P.-S.
Right arrow Articles by Kuo, M.-L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Article

CTGF enhances the motility of breast cancer cells via an integrin-{alpha}vβ3–ERK1/2-dependent S100A4-upregulated pathway

Pai-Sheng Chen1,2,*, Ming-Yang Wang1,2,3,*, Shin-Ni Wu1, Jen-Liang Su4,5,6, Chih-Chen Hong7, Shuang-En Chuang7, Min-Wei Chen1, Kuo-Tai Hua1, Yu-Ling Wu1, Shih-Ting Cha1, Munisamy Suresh Babu1, Chiung-Nien Chen2,3, Po-Huang Lee2,3, King-Jen Chang2,3,{ddagger},§ and Min-Liang Kuo1,2,{ddagger},§

1 Laboratory of Molecular and Cellular Toxicology, Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan
2 Angiogenesis Research Center, National Taiwan University, Taipei, Taiwan
3 Department of Surgery, National Taiwan University Hospital, Taipei 100, Taiwan
4 Graduate Institute of Cancer Biology, College of Medicine, China Medical University, Taichung 404, Taiwan
5 Center for Molecular Medical, China Medical University Hospital, Taichung 404, Taiwan
6 Department of Biotechnology and Bioinformatics, Asia University, Taichung 41354, Taiwan
7 Division of Cancer Research, National Health Research Institutes, Taipei 10016, Taiwan

{ddagger} Authors for correspondence (e-mails: kingjen{at}ntu.edu.tw; kuominliang{at}ntu.edu.tw)

Accepted 11 April 2007

Connective tissue growth factor (CTGF) expression is elevated in advanced stages of breast cancer, but the regulatory role of CTGF in invasive breast cancer cell phenotypes is unclear. Presently, overexpression of CTGF in MCF-7 cells (MCF-7/CTGF cells) enhanced cellular migratory ability and spindle-like morphological alterations, as evidenced by actin polymerization and focal-adhesion-complex aggregation. Reducing the CTGF level in MDA-MB-231 (MDA231) cells by antisense CTGF cDNA (MDA231/AS cells) impaired cellular migration and promoted a change to an epithelial-like morphology. A neutralizing antibody against integrin {alpha}vβ3 significantly attenuated CTGF-mediated ERK1/2 activation and cellular migration, indicating that the integrin-{alpha}vβ3–ERK1/2 signaling pathway is crucial in mediating CTGF function. Moreover, the cDNA microarray analysis revealed CTGF-mediated regulation of the prometastatic gene S100A4. Transfection of MCF-7/CTGF cells with AS-S100A4 reversed the CTGF-induced cellular migratory ability, whereas overexpression of S100A4 in MDA231/AS cells restored their high migratory ability. Genetic and pharmacological manipulations suggested that the CTGF-mediated S100A4 upregulation was dependent on ERK1/2 activation, with expression levels of CTGF and S100A4 being closely correlated with human breast tumors. We conclude that CTGF plays a crucial role in migratory/invasive processes in human breast cancer by a mechanism involving activation of the integrin-{alpha}vβ3–ERK1/2–S100A4 pathway.

Key words: Connective tissue growth factor, Breast cancer, ERK1/2, Integrin, S100A4, Cell migration, F-actin


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
M.-Y. Wang, P.-S. Chen, E. Prakash, H.-C. Hsu, H.-Y. Huang, M.-T. Lin, K.-J. Chang, and M.-L. Kuo
Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1
Cancer Res., April 15, 2009; 69(8): 3482 - 3491.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M.-H. Li, T. Sanchez, A. Pappalardo, K. R. Lynch, T. Hla, and F. Ferrer
Induction of Antiproliferative Connective Tissue Growth Factor Expression in Wilms' Tumor Cells by Sphingosine-1-Phosphate Receptor 2
Mol. Cancer Res., October 1, 2008; 6(10): 1649 - 1656.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2007